FDAnews Device Daily Bulletin

New Zealand Proposes to List New Hip, Knee Implants

Jan. 10, 2017

New Zealand’s medical device and drug regulator is proposing to let hospitals purchase orthopedic hip and knee implants made by Stryker New Zealand.

The Pharmaceutical Management Agency’s (PHARMAC) proposal would allow Stryker to supply about 3,700 orthopedic joint implants, additional craniomaxillofacial implants, cement, and associated products to District Health Board (DHB) hospitals.

DHBs could purchase Stryker’s devices at PHARMAC-negotiated prices starting Feb. 1, 2017, when the range of medical devices would be listed in Part III of Section H of the Pharmaceutical Schedule.

View today's stories